Home » Medical Devices » Gonorrhea Diagnostics Market

Gonorrhea Diagnostics Market – Growth, Future Prospects & Competitive Analysis, 2018-2026

Price: $4999

Published: | Report ID: 6415 | Report Format : PDF


Gonorrhea is caused by the infection of the bacterium Neisseria gonorrhea, which usually affects the moist and warm areas of the body, such as the vagina, anus, urethra, throat, and eyes. It is classified as the second most common sexually transmitted disease (STD) as it has the potential to spread through unprotected sex or multiple sexual partners. Due to the high morbidity rate and imminent threat of gonorrhea being resistant to cephalosporin, it is necessary to understand the disease epidemiology of gonorrhea. As per the latest research cited in the Centers for Disease Control and Prevention’s 2016 report, the global prevalence of gonorrhea is 142.1 cases per 100,000 people. The occurrence is higher in women in comparison to men and is widely prevalent in regions such as North America, Latin America, Africa, and other developing nations of South Asia.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

The World Health Organization has postulated a treatment guideline for gonorrhea in order to overcome the problem of microbial resistance, which consists of the use of antibiotics such as third-generation cephalosporins, doxycycline, azithromycin, gemifloxacin, etc. For effective diagnosis of gonorrhea, the cell culture standard test is considered the gold standard due to its inherent features such as high specificity, high sensitivity, and relatively low cost. The problems associated with the cell culture of Neisseria are the need to maintain bacterial viability during storage and transport, and approximately 24–72 hours are required before a preliminary culture test result is obtained. The nucleic acid amplification test (NAAT) has been approved by the USFDA for analyzing genital specimens only and has been beneficial in gaining positive results with very little genetic material, urine samples, and vaginal swabs. For analyzing extra-genital specimens, gonorrhea diagnosis is performed with serological tests, monoclonal antibody tests, flow cytometry, etc.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

The gonorrhea diagnostics market is segmented on the following basis:


  • Flow Cytometry
  • Diagnostic Imaging
  • Gel Microdroplets
  • Chromatography
  • Liposomes
  • Monoclonal antibody tests
  • Differential light scattering

Molecular diagnostic tests

  • Swab Tests
  • Nucleic Acid Amplification Tests (NAAT)


  • North America
  • United States
  • Canada


  • United Kingdom
  • Germany
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • rest of Latin America

Middle East and Africa

  • GCC
  • Rest of the Middle East and Africa

Key players identified for the gonorrhea diagnostics market include:

Abbott Laboratories, Agilent Technologies, Beckman Coulter, Inc., Becton Dickinson & Company, bioMérieux, Inc., Cepheid, Inc., PerkinElmer, Inc., Pfizer, Inc., Roche Diagnostics, and Siemens AG

This report offers:

  • The market assessment is done by furnishing the market size and compounded annual growth rate, considering 2017 as the base year and the period from 2018 to 2026 as the forecast period.
  • For the geography and type segments, an attractive investment proposition is given, which helps diagnostic manufacturers contemplate useful financial decisions.
  • The competitive landscape helps in determining the competitive milieu currently existing in the gonorrhea diagnostics market.
  • The financial health of leading players is considered in the financial information segment, and a diverse range of diagnostic kits and types are covered in the product portfolio section. Recent news coverage keeps us informed regarding the latest strategic developments and their impact on the gonorrhea diagnostics market.

Frequently Asked Questions:

What is the size of Gonorrhea Diagnostics Market?

The market for Gonorrhea Diagnostics is expected to reach US$ XX Bn in 2026.

What is the Gonorrhea Diagnostics Market CAGR?

The Gonorrhea Diagnostics market is expected to see significant CAGR growth over the coming years,at XX%.

What is the Forecast period considered for Gonorrhea Diagnostics Market?

The report is forecasted from 2018-2026.

What is the base year considered for Gonorrhea Diagnostics Market?

The base year of this report is 2017.

CSF (Cerebrospinal Fluid) Management Market

Report ID: 12389

Hypodermic Needles Market

Report ID: 6174

Implantable Infusion Pumps Market

Report ID: 12455

Medical Robots Market

Report ID: 42360

Magnetic Resonance Imaging (MRI) Systems Market

Report ID: 7815

Medical Device Technologies Market

Report ID: 42130

Transfection Reagents Market

Report ID: 41609

Intracranial Stents Market

Report ID: 7131

Hot And Cold Therapy Packs Market

Report ID: 7187

Digital Therapeutics Market

Report ID: 5029

Needles Market

Report ID: 41010

Microbial Contract Biomanufacturing Market

Report ID: 41008

Purchase Options

Delivery Format: Excel.
Designed for the individual purchaser.
Users located at a single corporate site or regional office.
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


+91 6232 49 3207


24/7 Research Support


– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN